Autoinflammatory diseases and cardiovascular manifestations

Annals of Medicine

Volumn 43, Issue 5, 2011, Pages 341-346

  Rigante, Donato ^a   Cantarini, Luca ^b   Imazio, Massimo ^c   Lucherini, Orso Maria ^b   Sacco, Emanuela ^a   Galeazzi, Mauro ^b   Brizi, Maria Giuseppina ^b   Brucato, Antonio ^d  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c MARIA VITTORIA HOSPITAL   (Italy)

^d OSPEDALI RIUNITI   (Italy)

Author keywords

Autoinfl ammatory diseases; cardiovascular abnormalities; familial Mediterranean fever; tumour necrosis factor receptor associated periodic syndrome

Indexed keywords

CARDIOVASCULAR DISEASE; FAMILIAL MEDITERRANEAN FEVER; GENE; GENE MUTATION; HUMAN; INFLAMMATORY DISEASE; MEFV GENE; PERICARDIAL DISEASE; PRIORITY JOURNAL; REVIEW; TNFRSF1A GENE; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME;

CARDIOVASCULAR DISEASES; CYTOSKELETAL PROTEINS; FAMILIAL MEDITERRANEAN FEVER; HEREDITARY AUTOINFLAMMATORY DISEASES; HUMANS; PERICARDITIS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I;

EID: 79959358691     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2010.547212     Document Type: Review

References (36)

1. Rigante D. The protean visage of systemic autoinflammatory syndromes: a challenge for inter-professional collaboration. Eur Rev Med Pharmacol Sci. 2010;14:1-18.
2. Grateau G. Clinical and genetic aspects of the hereditary periodic fever syndromes. Rheumatology. 2004;43: 410-5. (Pubitemid 38489355)
3. Guz G, Kanbay M, Ozturk MA. Current perspectives on familial Mediterranean fever. Curr Opin Infect Dis. 2009;22: 309-15.
4. Stehlik C, Reed JC. The pyrin connection: novel players in innate immunity and inflammation. J Exp Med. 2004;200: 551-8. (Pubitemid 39258304)
5. Papadopoulos VP, Giaglis S, Mitroulis I, Ritis K. The population genetics of familial Mediterranean fever: a meta-analysis study. Ann Hum Genet. 2008;72(Pt 6):752-61.
6. Booty MG, Chae JJ, Masters SL, Remmers EF, Barham B, Le JM, et al. Familial Mediterranean fever with a single MEFV mutation: where is the second hit? Arthritis Rheum. 2009;60:1851-61.
7. Lachmann HJ, Sengul B, Yavuzsen TU, Booth DR, Booth SE, Bybee A, et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford). 2006;45:746-50. (Pubitemid 43985345)
8. Touitou I, Sarkisian T, Medlej-Hashim M, Tunca M, Livneh A, Cattan D, et al. International Study Group for Phenotype-Genotype Correlation in Familial Mediterranean Fever. Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum. 2007; 56:1706-12. (Pubitemid 46764102)
9. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever: a survey of 470 cases and review of the literature. Am J Med. 1967;43:227-53.
10. Eliakim M, Ehrenfeld EN. Electrocardiographic changes in recurrent polyserositis ( 'periodic disease '). Am J Cardiol. 1961; 7:517-20.
11. Dabestani A, Noble LM, Child JS, Krivokapich J, Schwabe AD. Pericardial disease in familial Mediterranean fever: an echocardiographic study. Chest. 1982;81:592-5. (Pubitemid 12112329)
12. Zimaud S, Tauber T, Hegesch T, Aladjen M. Familial Mediterranean fever presenting with massive cardiac tamponade. Clin Exp Rheumatol. 1994;12:67-9. (Pubitemid 24045885)
13. Kees S, Langevitz P, Zemer D, Padeh S, Pras M, Livneh A. Attacks of pericarditis as a manifestation of familial Mediterranean fever (FMF). QJM. 1997;90:643-7. (Pubitemid 27453830)
14. Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, et al. Turkish FMF Study Group. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine. 2005;84:1-11. (Pubitemid 40130180)
15. Tutar E, Yalçinkaya F, Özcaya N, Ekim M, Atalay S. Incidence of pericardial effusion during attacks of familial Mediterranean fever. Heart. 2003;89:1257-8. (Pubitemid 37164033)
16. Okutur K, Seber S, Oztekin E, Bes C, Borlu F. Recurrent pericarditis as the initial manifestation of familial Mediterranean fever. Med Sci Monit. 2008;14:CS139-41.
17. Tutar HE, Imamoglu A, Kendirli T, Akar E, Atalay S, Akar N. Isolated recurrent pericarditis in a patient with familial Mediterranean fever. Eur J Pediatr. 2001;160:264-5. (Pubitemid 32250014)
18. Ozen S. Mutations/polymorphisms in a monogenetic autoinflammatory disease may be susceptibility markers for certain rheumatic diseases: lessons from the bedside for the benchside. Clin Exp Rheumatol. 2009;27(Suppl 53):S29-31.
19. Tekin M, Yalçinkaya F, Tümer N, Cakar N, Koçak H. Familial Mediterranean fever and acute rheumatic fever: a pathogenetic relationship? Clin Rheumatol. 1999;18:446-9. (Pubitemid 30014162)
20. Tutar E, Akar N, Atalay S, Yilmaz E, Akar E, Yalçinkaya F. Familial Mediterranean fever gene (MEFV) mutations in patients with rheumatic heart disease. Heart. 2002;87:568-9. (Pubitemid 34547988)
21. Grimaldi MP, Candore G, Vasto S, Caruso M, Caimi G, Hoffmann E, et al. Role of the pyrin M694V (A2080G) allele in acute myocardial infarction and longevity: a study in the Sicilian population. J Leukoc Biol. 2006;79: 611-5. (Pubitemid 44831237)
22. Akcay A, Acar G, Sayarlioglu M, Sokmen A, Kaya H, Ispiroglu M, et al. QT dispersion and transmural dispersion of repolarization in patients with familial Mediterranean fever. Mod Rheumatol. 2009;19:550-5.
23. Finkelstein Y, Aks SE, Hutson JR, Juurlink DN, Nguyen P, Dubnov-Raz G, et al. Colchicine poisoning: the dark side of an ancient drug. Clin Toxicol (Phila). 2010;48:407-14.
24. Halwani O, Delgado DH. Cardiac amyloidosis: an approach to diagnosis and management. Expert Rev Cardiovasc Ther. 2010;8:1007-13.
25. McDermott EM, Smillie DM, Powell RJ. Clinical spectrum of familial Hibernian fever: a 14-year follow-up study of the index case and extended family. Mayo Clin Proc. 1997;72: 806-17. (Pubitemid 27382920)
26. Dod é C, André M, Bienvenu T, Hausfater P, P êcheux C, Bienvenu J, et al. French Heraditary Recurrent Inflammatory Disorder Study Group. The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptorassociated periodic syndrome. Arthritis Rheum. 2002;46: 2181-8.
27. Aganna E, Hammond L, Hawkins PN, Aldea A, McKee SA, van Amstel HK, et al. Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes. Arthritis Rheum. 2003;48:2632-44. (Pubitemid 37129441)
28. Stojanov S, McDermott MF. The tumour necrosis factor receptor-associated periodic syndrome: current concepts. Expert Rev Mol Med. 2005;7:1-18.
29. Cantarini L, Lucherini OM, Baldari CT, Laghi Pasini F, Galeazzi M. Familial clustering of recurrent pericarditis may disclose tumour necrosis-factor receptor-associated periodic syndrome. Clin Exp Rheumatol. 2010;28:405-7.
30. Cantarini L, Lucherini OM, Cimaz R, Baldari CT, Bellisai F, Rossi Paccani S, et al. Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor associated periodic syndrome. Int J Immunopathol Pharmacol. 2009;22:1051-8.
31. Cantarini L, Lucherini OM, Cimaz R, Galeazzi M. Recurrent pericarditis caused by a rare mutation in the TNFRSF1A gene and with excellent response to anakinra treatment. Clin Exp Rheumatol. 2010;28:802.
32. Trost S, Rosé CD. Myocarditis and sacroiliitis: 2 previously unrecognized manifestations of tumor necrosis factor receptor associated periodic syndrome. J Rheumatol. 2005;32:175-7. (Pubitemid 40092609)
33. Roubille F, Cayla G, Gahide G, Mourad G, Macia JC. Acute myocarditis and tumor necrosis factor receptor-associated periodic (TRAP) syndrome: fi rst case described and discussion. Eur J Int Med. 2009;20:e25-6.
34. Stojanov S, Dejaco C, Lohse P, Huss K, Duftner C, Belohradsky BH, et al. Clinical and functional characterisation of a novel TNFRSF1A c.605T+ A/V173D cleavage site mutation associated with tumour necrosis factor receptorassociated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment. Ann Rheum Dis. 2008;67:1292-8.
35. Chia S, Qadan M, Newton R, Ludlam CA, Fox KA, Newby DE. Intra-arterial tumor necrosis factor-alpha impairs endotheliumdependent vasodilatation and stimulates local tissue plasminogen activator release in humans. Arterioscler Thromb Vasc Biol. 2003;23:695-701. (Pubitemid 36438086)
36. Cantarini L, Lucherini OM, Cimaz R, Brizi MG, Galeazzi M. Serosal involvement in adult-onset autoinflammatory disorders. Respiration. 2010;80:260-1.